Literature DB >> 20441600

Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report).

Astrid Dalhaug1, Ellinor Haukland, Carsten Nieder.   

Abstract

A case of leptomeningeal carcinomatosis in a patient with known brain and lung metastases from renal cell cancer without previous systemic therapy is presented. Neoplastic meningitis (NM) developed 31 months after first diagnosis of simultaneous extra- and intracranial recurrence of kidney cancer and surgical resection of a cerebellar metastasis. In spite of local radiotherapy to the macroscopic NM lesions in the cervical and lumbar spine followed by initiation of sunitinib, the patient succumbed to his disease 4 months after the diagnosis of NM. The untreated lung metastases progressed very slowly during almost 3 years of observation. This case illustrates important issues around both biological behaviour and treatment approaches in metastatic renal cell cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441600      PMCID: PMC2873341          DOI: 10.1186/1477-7819-8-36

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  19 in total

1.  Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5-fluorouracil and gemcitabine.

Authors:  D B Tippin; W Reeves; N J Vogelzang
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

2.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).

Authors:  Rafael Manon; Anne O'Neill; Jonathan Knisely; Maria Werner-Wasik; Hillard M Lazarus; Henry Wagner; Mark Gilbert; Minesh Mehta
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

4.  Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.

Authors:  Brian Shuch; Jeff C La Rochelle; Tobias Klatte; Stephen B Riggs; Weiqing Liu; Fairooz F Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 5.  The role of postoperative radiotherapy after resection of a single brain metastasis. Combined analysis of 643 patients.

Authors:  Carsten Nieder; Sabrina T Astner; Anca-Ligia Grosu; Nicolaus H Andratschke; Michael Molls
Journal:  Strahlenther Onkol       Date:  2007-10       Impact factor: 3.621

6.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

7.  Brain metastasis in renal cell cancer responding to sunitinib.

Authors:  Angelos K Koutras; Dimitrios Krikelis; Natassa Alexandrou; Ioannis Starakis; Haralabos P Kalofonos
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480

8.  Gamma Knife surgery for metastatic brain tumors without prophylactic whole-brain radiotherapy: results in 1000 consecutive cases.

Authors:  Toru Serizawa; Yoshinori Higuchi; Junichi Ono; Shinji Matsuda; Osamu Nagano; Yasuo Iwadate; Naokatsu Saeki
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

9.  Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.

Authors:  Dima Suki; Hiba Abouassi; Akash J Patel; Raymond Sawaya; Jeffrey S Weinberg; Morris D Groves
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

10.  Renal cell cancer presented with leptomeningeal carcinomatosis effectively treated with sorafenib.

Authors:  Oliver Ranze; Erich Hofmann; Andrea Distelrath; Heinz-Gert Hoeffkes
Journal:  Onkologie       Date:  2007-09-07
View more
  6 in total

1.  Clinical features and surgical management of four peculiar cases of intracranial metastases from renal cell carcinoma.

Authors:  Fuyou Guo; Junkuan Wang; Laijun Song; Hongwei Sun; Bo Yang; Xianzhi Liu; Shukai Wang
Journal:  Neurol Sci       Date:  2012-01-21       Impact factor: 3.307

2.  Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.

Authors:  Hui-Ming Chen; Ge Ma; Neil Gildener-Leapman; Samuel Eisenstein; Brian A Coakley; Junko Ozao; John Mandeli; Celia Divino; Myron Schwartz; Max Sung; Robert Ferris; Johnny Kao; Lu-Hai Wang; Ping-Ying Pan; Eric C Ko; Shu-Hsia Chen
Journal:  Clin Cancer Res       Date:  2015-04-28       Impact factor: 12.531

3.  Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience.

Authors:  Shlomit Yust-Katz; Samuel Mathis; Morris D Groves
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

4.  Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus.

Authors:  Celina M Crisman; Ankur R Patel; Graham Winston; Cameron W Brennan; Viviane Tabar; Nelson S Moss
Journal:  World Neurosurg       Date:  2020-04-03       Impact factor: 2.104

Review 5.  Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches.

Authors:  Giuseppe Lombardi; Fable Zustovich; Patrizia Farina; Alessandro Della Puppa; Renzo Manara; Diego Cecchin; Antonella Brunello; Alessandro Cappetta; Vittorina Zagonel
Journal:  Oncologist       Date:  2011-07-27

6.  Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization.

Authors:  Georges Sinclair; M Stenman; H Benmakhlouf; P Johnstone; P Wersäll; M Lindskog; M A Hatiboglu; U Harmenberg
Journal:  Surg Neurol Int       Date:  2020-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.